Use of human growth hormone in multiple system atrophy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/25 (2006.01) A61K 38/27 (2006.01) A61K 38/30 (2006.01) A61K 48/00 (2006.01) A61P 25/16 (2006.01)

Patent

CA 2532821

The invention relates to the use of a substance, which binds to and initiates signaling of the human growth hormone (hGH) receptor or a substance, which stimulates release or potentiates the activity of endogenous hGH, for treatment and/or prevention of Parkinsonism-Plus Syndromes. In particular, the invention relates to the use of hGH for the treatment and/or prevention of Multiple System Atrophy.

L'invention concerne l'utilisation d'une substance qui se lie au récepteur de l'hormone de croissance humaine (hGH) et déclenche la signalisation de ce dernier, ou à une substance qui stimule la libération ou potentialise l'activité de la hGH endogène, pour le traitement et la prévention de syndromes du parkinsonisme plus. L'invention se rapporte plus particulièrement à l'utilisation de la hGH pour le traitement et/ou la prévention de l'atrophie multisystème.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of human growth hormone in multiple system atrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of human growth hormone in multiple system atrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of human growth hormone in multiple system atrophy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1932824

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.